Update on the management of immune thrombocytopenic purpura in children

Current Opinion in Hematology

Volumn 14, Issue 5, 2007, Pages 526-534

  Tarantino, Michael D ^a,c   Bolton Maggs, Paula H B ^b  

^a Comprehensive Bleeding Disorders Center ^*  (United States)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Corticosteroids; Immune globulin; Purpura; Rituximab; Splenectomy; Thrombocytopenia

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; DANAZOL; DEXAMETHASONE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN; INTERFERON; MENINGOCOCCUS POLYSACCHARIDE VACCINE; MENINGOCOCCUS VACCINE; METHYLPREDNISOLONE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PREDNISOLONE; PREDNISONE; RHESUS D ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ANXIETY; ASEPTIC MENINGITIS; BLEEDING; BLOATING; CHILDHOOD; CHILL; CHRONIC DISEASE; CLINICAL TRIAL; DECISION MAKING; DEPRESSION; DIAGNOSTIC PROCEDURE; DYSPEPSIA; DYSPHORIA; EPISTAXIS; EXPERIENCE; FEVER; GLUCOSURIA; HEADACHE; HUMAN; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSOMNIA; NAUSEA; NAUSEA AND VOMITING; OBSERVATION; PLASMA TRANSFUSION; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RASH; REVIEW; SCORING SYSTEM; SERUM SICKNESS; SIDE EFFECT; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VOMITING; WEIGHT GAIN;

ADULT; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GREAT BRITAIN; HEMATOLOGY; HEMORRHAGE; HUMANS; IMMUNOLOGIC FACTORS; MALE; PLATELET COUNT; PRACTICE GUIDELINES AS TOPIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUALITY OF LIFE; RHO(D) IMMUNE GLOBULIN; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; SPLENECTOMY; UNITED STATES;

EID: 34648812790     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3282ab98df     Document Type: Review

References (73)

1. Buchanan GR, Holtkamp CA. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura: a randomized clinical trial. Am J Pediatr Hematol Oncol 1984; 6:355-361.
2. Lusher JM, Emami A, Ravindranath Y, Warrier AI. Idiopathic thrombocytopenic purpura in children: the case for management without corticosteroids. Am J Pediatr Hematol Oncol 1984; 6:149-157.
3. Kuhne T, Imbach P, Bolton-Maggs PH, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001; 358:2122-2125.
4. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
5. Sutor AH, Dickerhoff R, Gaedicke G, Pollmann H. Hämostasiologie: acute postinffektioẍse immunthrombozytopenie im kindersalter [Acute postinfectious immune thrombocytopenia in children]. In: Reinhard D, Cruetzig U, Kiess W, et al., editors. Leitlinien kenderheilkunde und jugendmedizin [Guidelines for pediatric and youth medicine]. Munich: Urban & Fischer; 1999. pp. 23-27.
6. De Mattia D, Del Principe D, Del Vecchio GC, et al. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica'. Haematologica 2000; 85:420-424.
7. Shirahata A, Ishii E, Eguchi H, et al. Consensus guideline for diagnosis and treatment of childhood idiopathic thrombocytopenic purpura. Int J Hematol 2006; 83:29-38.
8. Sutor AH. Acute immune thrombocytopenia in childhood: are we treating the platelet count? Semin Thromb Hemost 1998; 24:545-548.
9. BCSH. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120:574-596.
10. Jaing TH, Tsay PK, Hung IJ, et al. The role of Helicobacter pylori infection in children with acute immune thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47:215-217.
11. Hayashi H, Okuda M, Aoyagi N, et al. Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura. Pediatr Int 2005; 47:292-295.
12. Vesely S, Buchanan GR, Cohen A, et al. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol 2000; 22:55-61.
13. Klaassen RJ, Doyle JJ, Krahn MD, et al. Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: decision analysis. J Pediatr Hematol Oncol 2001; 23:511-518.
14. Dubansky AS, Boyett JM, Falletta J, et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group Study. Pediatrics 1989; 84:1068-1071.
15. Calpin C, Dick P, Poon A, Feldman W. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med 1998; 152:345-347.
16. Dubansky AS, Oski FA. Controversies in the management of acute idiopathic thrombocytopenic purpura: a survey of specialists. Pediatrics 1986; 77:49-52.
17. Reid MM. Bone marrow examination before steroids in thrombocytopenic purpura or arthritis. Acta Paediatr 1992; 81:1052-1053.
18. Kuhne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003; 143:605-608.
19. Imbach P, Kuhne T, Muller D, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006; 46:351-356.
20. Buchanan G, Kuhne T, Bolton-Maggs PHB, et al. Frequency, location and timing of severe hemorrhage in children with newly-diagnosed ITP: a study of the Intercontinental Childhood ITP Study Group. Blood 2003; 102:298a.
21. Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 2000; 137:629-632.
22. Bolton-Maggs PH, Dickerhoff R, Vora AJ. The nontreatment of childhood ITP (or the art of medicine consists of amusing the patient until nature cures the disease). Semin Thromb Hemost 2001; 27:269-275.
23. Roganovic J, Letica-Crepulja M. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia. Pediatr Blood Cancer 2006; 47 (5 Suppl):662-664.
24. Baronci C, Petrone A, Miano C, et al. Treatment of acute idiopathic thrombocytopenic purpura in children: a retrospective evaluation of 120 cases. Ann Ist Super Sanita 1998; 34:457-461.
25. Tarantino MD, Young G, Bertalone SJ, et al. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count I in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr 2006; 148:489-494. A recent prospective randomized trial of anti-D immune globulin, at one of two doses, compared with single-dose IVIg as initial treatment of ITP in children.
26. Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997; 350:620-623. A national audit of management of ITP in the UK polling all paediatricians and haematologists, which demonstrated that most children with acute ITP have very few bleeding symptoms despite very low platelet counts.
27. Bolton-Maggs PHB, Moon I. Closing the audit loop: outcome of the second national audit of the management of acute ITP: a change in practice. Blood 2001; 98:58b.
28. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 2001; 27:253-267.
29. Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003; 25 (Suppl 1):S47-S51.
30. Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 2005; 94:178-184.
31. Rosthøj S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr 2003; 143:302-307.
32. Chandra J, Ravi R, Singh V, et al. Bleeding manifestations in severely thrombocytopenic children with immune thrombocytopenic purpura. Hematology 2006; 11:131-133.
33. Vesely SK, Buchanan GR, Adix L, et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003; 25:130-133.
34. Sandoval C, Visintainer P, Ozkaynak MF, et al. Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura. Pediatr Blood Cancer 2004; 42:109-112.
35. Bolton-Maggs PH. Acute idiopathic thrombocytopenic purpura - management in childhood. Blood 1997; 89:1465; author reply 1466.
36. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002; 141:683-688.
37. Watson S, Bolton-Maggs PHB. Management strategies in immune thrombocytopenic purpura (ITP): more than medication: what do the patients think? Blood 2000; 96:438a.
38. Barnard D, Woloski M, Feeny D, et al. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol 2003; 25:56-62.
39. Klaassen RJ, Blanchette VS, Barnard D, et al. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools. J Pediatr 2007; 150:510-515, 515.e1.
40. von Mackensen S, Nilsson C, Jankovic M, et al. Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL). Pediatr Blood Cancer 2006; 47 (5 Suppl):688-691.
41. Carcao MD, Zipursky A, Butchart S, et al. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998; 424:71-74.
42. Rosthoj S, Nielsen S, Pedersen FK. Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Danish I.T.P. Study Group. Acta Paediatr 1996; 85:910-915.
43. Duru F, Fisgin T, Yarali N, Kara A. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy. Pediatr Hematol Oncol 2002; 19:219-225.
44. Ancona KG, Parker RI, Atlas MP, Prakash D. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2002; 24:540-544.
45. Erduran E, Aslan Y, Gedik Y, Orhan F. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura. Turk J Pediatr 2003; 45:295-300.
46. Wali YA, Al Lamki Z, Shah W, et al. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 2002; 19:329-335.
47. Hedlund-Treutiger I, Henter JI, Elinder G, et al. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003; 25:139-144.
48. Monteleone PM, Vander Heyden MA, Steele DA, Kelleher JF. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study. Haematologica 2000; 85:887-888.
49. Moser AM, Shalev H, Kapelushnik J. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 2002; 19:407-411.
50. Tarantino MD, Madden RM, Fennewald DL, et al. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 1999; 134:21-26.
51. El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. Acta Haematol 2006; 115:46-52.
52. Bennett CM, Rogers ZR, Kinnamon DD, et al. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 2006; 107:2639-2642. An important prospective open-label trial of rituximab for children with severe refractory ITP.
53. Wang J, Wiley JM, Luddy R, et al. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. J Pediatr 2005; 146:217-221. An important prospective open-label trial of rituximab for children with chronic ITP.
54. Taube T, Schmid H, Reinhard H, et al. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood. Haematologica 2005; 90:281-283.
55. Parodi E, Nobili B, Perrotta S, et al. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment. Int J Hematol 2006; 84:48-53.
56. Beck CE, Nathan PC, Parkin PC, et al. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr 2005; 147:521-527. A systematic review of randomized trials comparing the safety and efficacy of various corticosteroid regimens, including mega-dose methylprednisolone, with IVIg regimens.
57. Newman GC, Novoa MV, Fodero EM, et al. A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura'. Br J Haematol 2001; 112:1076-1078.
58. Kjaersgaard M, Hasle H. A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47 (5 Suppl):717-720.
59. Gaines AR. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005; 106:1532-1537.
60. Kees-Folts D, Abt AB, Domen RE, Freiberg AS. Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura. Pediatr Nephrol 2002; 17:91-96.
61. Levendoglu-tugal O, Jayabose S. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr-virus-related thrombocytopenia. J Pediatr Hematol/Oncol 2001; 23:460-463.
62. Olofinboba KA, Greenberg BR. Successful treatment of infectious mononucleosis-associated immune thrombocytopenia with WinRho anti-D immunoglobulin complicated by severe hemolysis. Am J Hematol 2000; 65:178.
63. Gaines AR. Acute onset hemoglobin hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000; 95:2523-2529.
64. Meyer O, Kiesewetter H, Hermsen M, Salama A. Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia. Eur J Haematol 2004; 73:71-72.
65. Meyer O, Kiesewetter H, Hermsen M, et al. Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia. Pediatr Blood Cancer 2006; 47 (5 Suppl):721-722.
66. Reid MM. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child 1995; 72:125-128.
67. Donato H, Picon A, Rapetti MC, et al. Splenectomy and spontaneous remission in children with chronic idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47 (5 Suppl):737-739.
68. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994; 330:1560-1564.
69. Beham ES, Taft LI. Idiopathic thrombocytopenic purpura in children: results of steroid therapy and splenectomy. Aust Paediatr J 1972; 8:311-317.
70. Mantadakis E, Buchanan GR. Elective splenectomy in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2000; 22:148-153.
71. Lowe EJ, Buchanan GR. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatr 2002; 141:253-258.
72. Aronis S, Platokouki H, Avgeri M, et al. Retrospective evaluation of long-term efficacy and safety of splenectomy in chronic idiopathic thrombocytopenic purpura in children. Acta Paediatr 2004; 93:638-642.
73. Wang T, Xu M, Ji L, Yang R. Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China. Acta Haematol 2006; 115:39-45.